No abstract available
MeSH terms
-
Antiparkinson Agents / adverse effects
-
Antiparkinson Agents / therapeutic use
-
Basal Ganglia Diseases / chemically induced*
-
Basal Ganglia Diseases / drug therapy
-
Basal Ganglia Diseases / prevention & control
-
Butyrophenones / adverse effects
-
Chlorpromazine / adverse effects
-
Drug Therapy, Combination
-
Humans
-
Iatrogenic Disease
-
Parasympatholytics / therapeutic use
-
Piperazines / adverse effects
-
Piperidines / adverse effects
-
Psychotic Disorders / drug therapy
-
Time Factors
Substances
-
Antiparkinson Agents
-
Butyrophenones
-
Parasympatholytics
-
Piperazines
-
Piperidines
-
Chlorpromazine